Invention Grant
- Patent Title: Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent Title (中): 含有SGLT2抑制剂的药物制剂
-
Application No.: US12949473Application Date: 2010-11-18
-
Publication No.: US08221786B2Publication Date: 2012-07-17
- Inventor: Dilbir S. Bindra , Mandar V. Dali , Prakash V. Parab , Jatin M. Patel , Li Tao , Ravindra W. Tejwani , Nipa Vatsaraj , Yongmei Wu
- Applicant: Dilbir S. Bindra , Mandar V. Dali , Prakash V. Parab , Jatin M. Patel , Li Tao , Ravindra W. Tejwani , Nipa Vatsaraj , Yongmei Wu
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: A61K9/48
- IPC: A61K9/48 ; A61K31/70 ; A61K9/30 ; A61P3/00 ; A61P9/00
Abstract:
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate and a pharmaceutical acceptable carrier therefor, which formulation is designed for immediate release.
Public/Granted literature
- US20110064801A1 Pharmaceutical Formulations Containing an SGLT2 Inhibitor Public/Granted day:2011-03-17
Information query
